The science
Niacinamide's dermatological evidence base is broad, and it is worth being precise about the doses at which it was gathered, because this serum exceeds all of them. The sebum-control claim rests on a 2006 study in the Journal of Cosmetic and Laser Therapy in which 2 percent topical niacinamide, applied for four weeks in Japanese subjects and six weeks in Caucasian subjects, significantly lowered sebum excretion rate in the first group and casual surface sebum levels in the second compared with placebo. The acne evidence comes from a 1995 randomised trial in the International Journal of Dermatology comparing 4 percent nicotinamide gel with 1 percent clindamycin gel in 76 patients with moderate inflammatory acne over eight weeks; both produced comparable improvement, with about 82 percent of the niacinamide group improving, and the nicotinamide had the advantage of not driving antibiotic resistance. Its anti-pigment effect, through inhibition of melanosome transfer from melanocytes to keratinocytes, and its barrier effect, through increased ceramide and keratin synthesis, were established at 2 to 5 percent. No controlled trial has compared 12 percent with 5, and pharmacologically there is little reason to expect a gain: niacinamide is a small, water-soluble molecule that penetrates readily, its cellular targets saturate, and the main dose-dependent effect above 5 percent is a transient flushing that reviewers of high-dose serums describe with some regularity. Zinc PCA is less studied; zinc salts have in vitro evidence for reducing 5-alpha-reductase activity and sebocyte lipid output and for antimicrobial action against Cutibacterium acnes, and PCA is a native component of the skin's natural moisturising factor, so the pairing is rational for oily skin though its clinical data are thin. The vehicle is a simple aqueous gel thickened with xanthan, sclerotium gum and hydroxyethylcellulose, which suits a water-soluble active and explains the tackiness at high application volumes. The seed polysaccharide labelled botanical hyaluronic acid is a galactomannan with surface film-forming and humectant properties and no structural relationship to hyaluronic acid. The evidence therefore supports this serum's oil-control and blemish claims at a dose well below the one on the label, and offers nothing to justify the higher number beyond marketing.
References 2 ShowHide
- The effect of 2% niacinamide on facial sebum production — Journal of Cosmetic and Laser Therapy (2006)
- Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris — International Journal of Dermatology (1995)